Thus, an initial study by Yamauchi et al. provided evidence that the frequency of CIMP-high, MSI-high and BRAF mutations gradually increased from rectum to ascending colon; in contrast, the frequency of KRAS mutations remained relatively stable at various tumor sites [97,234]. Here, BRAF is linked to neoplasm.